Full Text View
Tabular View
No Study Results Posted
Related Studies
Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity
This study is currently recruiting participants.
Verified January 2014 by Memorial Sloan-Kettering Cancer Center
Study NCT01323517   Information provided by Memorial Sloan-Kettering Cancer Center

First Received on March 23, 2011.   Last Updated on January 6, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial